AIDS News and Research

RSS

Olympus launches forward-viewing curvilinear ultrasound gastrovideoscope

Olympus, a precision technology leader in designing and delivering innovative solutions in the medical and surgical field, among other core businesses, announced today the launch of its 510(k) cleared and world's only forward-viewing curvilinear ultrasound gastrovideoscope.

From Evident Corporation - Life Sciences 10 Oct 2013

Researchers recently launched Collaborative Hepatitis Network in Africa

Although it does not receive as much attention as AIDS, hepatitis has long been one of Africa's most serious health problems.

9 Oct 2013

New HIV vaccines stimulate critical immune response in infants born to HIV-infected mothers

A new analysis of two HIV vaccine trials that involved pediatric patients shows that the investigational vaccines stimulated a critical immune response in infants born to HIV-infected mothers, researchers at Duke Medicine report.

9 Oct 2013

Ramsell partners with Alameda County to provide pharmacy benefits management services

Ramsell, a leading provider of innovative solutions for organizations that serve the underserved, today announced a new partnership with Alameda County Behavioral Health Care Services to provide pharmacy benefits management services to more than 900 low-income mental health patients.

9 Oct 2013

Scientists to highlight Bio-Rad's Droplet Digital PCR applications at CHI Digital PCR Conference

Since its introduction in 2011, Bio-Rad Laboratory's Droplet Digital PCR (ddPCR-) technology has demonstrated the potential to be a transformative technology, particularly in clinical applications.

8 Oct 2013

In South Africa, rapid progress in reducing under-five mortality

Over the past decade, South Africa has made a dramatic reversal in child survival-mainly because of improvements in HIV/AIDS care, reports a study in AIDS, official journal of the International AIDS Society. AIDS is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

8 Oct 2013

LSUHSC receives $2.76M grant to study how HIV affect oral bacterial communities

Dr. Paul Fidel, the Carl Baldridge Professor and Associate Dean for Research at LSU Health Sciences Center New Orleans' School of Dentistry, is the lead principal investigator of a $2.76 million grant from the National Institute of Dental and Craniofacial Research over five years to study how HIV and antiretroviral therapy may change communities of bacteria in the mouth and what effects those changes may have on oral infections in HIV disease.

8 Oct 2013

Newly discovered compound could be developed as antifungal drug to treat fungal infections

On a molecular level, you have more in common with shower curtain mold or the mushrooms on your pizza than you might think. Humans and fungi share similar proteins, a biological bond that makes curing fungal infections difficult and expensive.

7 Oct 2013

Bioactive compounds in carrot can be used as antiviral for treatment against flu

Researchers from the FEMSA Center of Biotechnology at Technologic of Monterrey (ITESM) designed a technology that uses grated carrot to obtain phenolic compounds that have a potential to prevent cancer, and cardiovascular and neurodegenerative diseases.

5 Oct 2013

Scientists identify chemical agents that block flu virus's ability to replicate itself in cell culture

A new way to attack flu viruses is taking shape in laboratories at Rutgers University, where scientists have identified chemical agents that block the virus's ability to replicate itself in cell culture.

4 Oct 2013

FDA report reveals personal, professional devastation caused by cognitive dysfunctions of ME/CFS

PANDORA Org and other patient organizations say a recent report from the U.S. Food and Drug Administration (FDA) shows the agency must take further action to open up opportunities for ME/CFS drug development.

4 Oct 2013

MTN-017 study launched to test reduced glycerin formulation of tenofovir gel

IRMA applauds the launch of the world's first-ever Phase II rectal microbicide trial. The Microbicide Trial Network's study, called MTN-017, will test a reduced glycerin formulation of tenofovir gel applied rectally.

3 Oct 2013

UCLA study shows how cocaine makes immune cells susceptible to HIV

In many ways, the spread of HIV has been fueled by substance abuse. Shared needles and drug users' high-risk sexual behaviors are just some of the ways that narcotics such as cocaine have played a key role in the AIDS epidemic in much of the world.

3 Oct 2013

State highlights: NYC's plan to get bids for worker coverage meets roadblock; Iowa waits for Medicaid expansion waiver, readies enrollment

New York City's plan to solicit bids for health insurance for hundreds of thousands of workers has been put on hold. A Manhattan judge on Monday granted a preliminary injunction preventing the City from issuing the bids. A group of unions sued the city Aug. 10, shortly after Mayor Michael Bloomberg said the city was planning to seek bids within days. Bloomberg said the request for proposals will look to save up to $400 million a year (10/1)

2 Oct 2013

NIH awards 10 new grants to support genomics research in Africa

The National Institutes of Health has awarded 10 new grants totaling up to $17 million over the next four years to support genomics research in Africa, as part of the Human Heredity and Health in Africa (H3Africa) program

2 Oct 2013

First Edition: October 1, 2013

Today's headlines detail how the federal government has been shutdown as a result of the ongoing congressional battle over the health law. Still, even as House and Senate lawmakers were unable to overcome this issue to reach a deal to provide funding to continue government operations, Oct. 1 is still the official launch of the overhaul's online insurance marketplaces.

1 Oct 2013

Study to assess voluntary HIV testing, prompt treatment in South Africa, Zambia

A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.

1 Oct 2013

Use of cocaine may increase one's vulnerability to HIV infection

Cocaine use may increase one's vulnerability to HIV infection, according to a new research report published in the Journal of Leukocyte Biology. In the report, scientists show that cocaine alters immune cells, called "quiescent CD4 T cells," to render them more susceptible to the virus, and at the same time, to allow for increased proliferation of the virus.

1 Oct 2013

Avahan AIDS initiative effective at controlling HIV infections in India

A programme funded by the Bill & Melinda Gates Foundation may have saved around 600,000 people in India from becoming infected with HIV over the course of a decade, according to a new report.

1 Oct 2013

Innovative packaging design aids convergence in the pharmaceutical industry

PCI, a global supplier of pharmaceutical commercial packaging solutions and clinical trials services, announces the availability of a white paper detailing how it’s innovative packaging design aids convergence in the pharmaceutical industry.

30 Sep 2013

AIDS News and Research

Olympus launches forward-viewing curvilinear ultrasound gastrovideoscope

Researchers recently launched Collaborative Hepatitis Network in Africa

New HIV vaccines stimulate critical immune response in infants born to HIV-infected mothers

Ramsell partners with Alameda County to provide pharmacy benefits management services

Scientists to highlight Bio-Rad's Droplet Digital PCR applications at CHI Digital PCR Conference

In South Africa, rapid progress in reducing under-five mortality

LSUHSC receives $2.76M grant to study how HIV affect oral bacterial communities

Newly discovered compound could be developed as antifungal drug to treat fungal infections

Bioactive compounds in carrot can be used as antiviral for treatment against flu

Scientists identify chemical agents that block flu virus's ability to replicate itself in cell culture

FDA report reveals personal, professional devastation caused by cognitive dysfunctions of ME/CFS

MTN-017 study launched to test reduced glycerin formulation of tenofovir gel

UCLA study shows how cocaine makes immune cells susceptible to HIV

State highlights: NYC's plan to get bids for worker coverage meets roadblock; Iowa waits for Medicaid expansion waiver, readies enrollment

NIH awards 10 new grants to support genomics research in Africa

First Edition: October 1, 2013

Study to assess voluntary HIV testing, prompt treatment in South Africa, Zambia

Use of cocaine may increase one's vulnerability to HIV infection

Avahan AIDS initiative effective at controlling HIV infections in India

Innovative packaging design aids convergence in the pharmaceutical industry

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News